Close
CDMO Safety Testing 2026
Novotech

Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Decentralized Clinical Trials Market Advances Worldwide

The global Decentralized Clinical Trials Market is expected to...

Quantum Computing Enhancing Clinical Trial Design

The modernization of clinical development is undergoing a massive shift as quantum-based optimization tools are integrated into trial architectures. By improving patient selection and simulating physiological responses at a molecular level, these technologies are reducing the high failure rates associated with traditional research phases. This evolution toward digital and adaptive trials ensures that therapeutic candidates are tested more efficiently, leading to faster regulatory approvals and a more streamlined path for delivering life-saving treatments to the public.
- Advertisement -

Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in Amsterdam, The Netherlands.

Currently used in trials with nine Pharma companies, including two of the top five, for a variety of electronic data capture (EDC) and direct data capture eSource clinical trials, the solution provides sponsors and their partners with a single point of access for live views of data at any point in a clinical trial.

Using encapsia’s eSource app, sites can capture source data directly from patients in a way that seamlessly integrates with clinical workflows. This eliminates the time lost between a patient’s visit, and clean, verified data being made available for decision-making.

David Connelly, Chief Executive Officer, Cmed, comments: “We have considerable expertise and experience in designing data management systems, conducting full service studies and providing stand-alone Biometrics services, including for some of the world’s largest pharmaceutical companies. We understand our customers’ needs, the challenging operational and regulatory environment and have responded by applying our technology and expertise to implement live data analytics and clinical data science.”

“Today’s trials often have data residing in multiple systems and databases. During the conference we will be demonstrating how encapsia provides an all-in-one system for eSource, web EDC, risk-based monitoring, remote monitoring, data management and live reporting, offering immediate clinical trial data, captured and consolidated from all sources, with live on-going analysis and actionable insights. While encapsia has all the apps needed to conduct full enterprise clinical data management, it can also be integrated with other vendor systems. Sponsor feedback on encapsia is very positive, with the solution reducing project timelines by 3 weeks for one client and facilitating dose escalation decisions via live data access.”

Visitors are invited to join Cmed at booth #109a during Partnerships in Clinical Trials Europe. To schedule a meeting with the Cmed team, please contact Louise Holliday, Director, Business Development – lholliday@cmedresearch.com

For further information on Cmed, please visit www.cmedresearch.com

About Cmed
Cmed is an innovative, full service technology-led CRO. Cmed brings together experienced people and technology, providing customers with a friendly, proactive service, and delivers this service using advanced clinical data capture, management and reporting software and processes. Cmed’s new generation clinical data suite, encapsia™, streamlines the capture, management and reporting of clinical data, saving customers time and money. Clinical data can be captured flexibly by eSource, multi-media and web eDC, while being displayed in live visual insights, providing live analytics, and allowing within suite audit trailed actions. It is fully compliant with regulatory guidelines, and allows integration with existing systems.

World Pharma Today brings together the global pharmaceutical industry — from R&D leaders and regulatory affairs professionals to manufacturers and distribution executives — through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium pharmaceutical industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global pharmaceutical and life sciences value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.

Latest stories

Related stories

Decentralized Clinical Trials Market Advances Worldwide

The global Decentralized Clinical Trials Market is expected to...

Quantum Computing Enhancing Clinical Trial Design

The modernization of clinical development is undergoing a massive shift as quantum-based optimization tools are integrated into trial architectures. By improving patient selection and simulating physiological responses at a molecular level, these technologies are reducing the high failure rates associated with traditional research phases. This evolution toward digital and adaptive trials ensures that therapeutic candidates are tested more efficiently, leading to faster regulatory approvals and a more streamlined path for delivering life-saving treatments to the public.

FDA Advances Real-Time Clinical Trials With AstraZeneca, Amgen

The U.S. Food and Drug Administration has unveiled a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »